Share Holdings

PERK PHARMACEUTICALS LTD.

NSE : NABSE : 530673ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE1.980 (0 %)
PREV CLOSE ( ) 1.98
OPEN PRICE ( ) 1.98
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )1.98 1.98
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
ParticularsJun2010Mar2010var%Dec2009Sep2009var%
Promoter and Promoter Group
Indian Promoters52.352.3052.352.30
    Individuals / Hindu Undivided Family28.8928.89028.8928.890
    Central Government/State Government(s)
    Bodies Corporate
    Financial Institutions / Banks
    Partnership Firms
    Promoter Group
    Employees Welfare Fund
    Other23.4123.41023.4123.410
    Any Others (Specify)23.4123.41023.4123.410
Foreign Promoters
    Non-Residents Individuals / Foreign Individuals
    'Bodies Corporate
    Institutions
    Other
Any Others (Specify)
Total of Promoter and Promoter Group52.352.3052.352.30
Public Shareholding
Institutions
    Mutual Funds / UTI
    Financial Institutions / Banks
    Insurance Companies
    Foreign Institutional Investors
    Venture Capital Funds
    Foreign Venture Capital Investors
    Alternate Investment Funds
    Foreign Portfolio investors
    Provident funds / Pension funds
    Multilateral & Bileteral Development Financial Institution
    Any Others (Specify)
    Central Government / State Government(s)
    Foreign Financial Institutions / Banks
    Stressed Assets Stabilisation Fund
    Foreign Financial Institutions
    State Finance Corporation
    Foreign Bodies DR
    Other
Non-Institutions47.747.7047.747.70
    Bodies Corporate0.820.8200.820.820
    Individuals
    Individual shareholders holding nominal share capital up to Rs. 1 lakh36.2936.29036.2936.280
    Individual shareholders holding nominal share capital in excess of Rs. 1 lakh3.343.3403.343.340
    NBFCs Registed with RBI
    Employee Trusts
    Any Others (Specify)7.257.2507.257.270.03
    Clearing Members
    Non Resident Indians7.257.2507.257.270.03
    Directors & their Relatives & Friends
    Foreign Collaborators
    Foreign Mutual Fund
    Trusts
    Hindu Undivided Families
    Foreign Corporate Bodies
    Shares in transit
    Market Maker
    ESOP/ESOS/ESPS
    Societies
    Escrow Account
    Any Other
Total Public Shareholding47.747.7047.747.70
 
Total of Promoter and Public Shareholding10010001001000
 
    Shares held by Custodians and against which Depository Receipts have been issued00
    American Depository Receipts
    GDRs
Others
 
Grand Total10010001001000

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.